A new type of painkiller aimed at treating pain from an injury or surgery has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, also known by its brand name Journavx, ...
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will host a virtual investor event and conference call today at ...
Learn how common medications like nitroglycerin, antidepressants, and hormone therapies can trigger migraine attacks.
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
Add videos to your saved list and come back to them any time.
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...